Last reviewed · How we verify

NCT05633212

Binocular Vision Alternations and fMRI Activation After ICL Implantation for High Myopia

Status unknown Last updated 1 December 2022
What this trial tests

trial in Binocular Vision Disorder in 50 participants. Status unknown.

Timeline
15 March 2022
Primary endpoint
30 June 2023
30 June 2023

Quick facts

Lead sponsorZhongshan Ophthalmic Center, Sun Yat-sen University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date15 March 2022
Primary completion30 June 2023
Estimated completion30 June 2023
Sites1 location across China

Conditions studied

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Who can join

Adults 18 to 35, any sex, with Binocular Vision Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Implantable collamer lens (ICL) is one of the most effective operation for high myopia. Due to refractive correction changed, and prism effect of the spectacle removed, in the early stage after ICL implantation, binocular function might be dysfunction, leading to asthenopia, blurred vision, double vision and so on. This study will recruit the high myopia subjects that scheduled for ICL implantation, purpose to investigate the binocular vision alternations and brain activation that impacted by ICL implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zhongshan Ophthalmic Center, Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05633212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing